Approval · Notice of Compliance 28742 · 2022
AMPROLIUM SOLUTION: Notice of Compliance 28742
Issued August 15, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28742
- Date
- August 15, 2022
- Company
- Bio Agri Mix LpMitchell, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- AMPROL (Huvepharma Eood)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMPROLIUM SOLUTION | 02529726 | Marketed |
Medicinal ingredients
- AMPROLIUM 9.6 PER